• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Campbell Appoints Carrie Anderson Chief Financial Officer

    1/25/23 4:30:00 PM ET
    $CPB
    $EMBC
    $IART
    Packaged Foods
    Consumer Staples
    Medical/Dental Instruments
    Health Care
    Get the next $CPB alert in real time by email

    Campbell Soup Company (NYSE:CPB) today announced the appointment of Carrie L. Anderson as Executive Vice President and Chief Financial Officer, effective Feb. 6.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230125005725/en/

    Carrie Anderson (Photo: Business Wire)

    Carrie Anderson (Photo: Business Wire)

    Anderson will lead Campbell's finance function, including controllership, corporate financial planning and analysis, corporate strategy and development, tax, treasury, internal audit, investor relations, transactional services and financial systems. She will report to Campbell's President and Chief Executive Officer Mark Clouse and become a member of the company's Operating Committee and a Corporate Officer. Anderson succeeds Mick Beekhuizen, who was appointed President of Campbell's Meals & Beverages division in November 2022.

    "I am delighted to welcome Carrie to our leadership team. She brings a wide range of diverse, strategic experience and financial discipline, and her expertise in capital management and deployment will help us continue to drive our growth plans and enhance our performance," said Clouse. "Her collaborative approach combined with a track record of driving transformation, delivering results and developing strong finance teams will be invaluable as we continue to build momentum in the business."

    Anderson brings a wealth of financial experience working in a variety of complex industries, as well as a background in manufacturing and engineering. She joins Campbell from Integra LifeSciences (NASDAQ:IART), a leading global medical technology company, where she has served as Executive Vice President and Chief Financial Officer since 2019. Before Integra, Anderson spent seven years with Dover Corporation in several leadership roles, including Chief Accounting Officer/Corporate Controller, and Vice President and CFO for the company's engineered systems and printing and identification businesses. Previously, Anderson spent six years as Vice President and Chief Financial Officer of Delphi Product & Service Solutions, a division of Delphi Corporation. While at Delphi, she also held leadership positions in finance, treasury and investor relations. Anderson started her career with General Motors.

    Anderson earned her B.S. in chemical engineering from Purdue University and an MBA from Ball State University. She serves on the board of directors of Embecta Corp. (NASDAQ:EMBC) and is a member of its Audit and Nominating & Governance committees.

    About Campbell Soup Company

    For more than 150 years, Campbell (NYSE:CPB) has been connecting people through food they love. Generations of consumers have trusted Campbell to provide delicious and affordable food and beverages. Headquartered in Camden, N.J. since 1869, Campbell generated fiscal 2022 net sales of nearly $8.6 billion. Our portfolio includes iconic brands such as Campbell's, Cape Cod, Goldfish, Kettle Brand, Lance, Late July, Milano, Pace, Pacific Foods, Pepperidge Farm, Prego, Snyder's of Hanover, Swanson and V8. Campbell has a heritage of giving back and acting as a good steward of the environment. The company is a member of the Standard & Poor's 500 as well as the FTSE4Good and Bloomberg Gender-Equality Indices. For more information, visit www.campbellsoupcompany.com or follow company news on Twitter via @CampbellSoupCo.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230125005725/en/

    Get the next $CPB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CPB
    $EMBC
    $IART

    CompanyDatePrice TargetRatingAnalyst
    The Campbell's Company
    $CPB
    8/20/2025$33.00Neutral
    Analyst
    The Campbell's Company
    $CPB
    8/7/2025$34.00Overweight → Neutral
    Piper Sandler
    The Campbell's Company
    $CPB
    6/20/2025Buy → Hold
    Argus
    The Campbell's Company
    $CPB
    4/23/2025$36.00Sell
    UBS
    Embecta Corp.
    $EMBC
    4/10/2025$15.00Neutral
    Mizuho
    Integra LifeSciences Holdings Corporation
    $IART
    3/31/2025Hold → Buy
    Argus
    The Campbell's Company
    $CPB
    3/17/2025Overweight → Equal Weight
    Consumer Edge Research
    The Campbell's Company
    $CPB
    3/6/2025$48.00 → $37.00Overweight → Neutral
    Analyst
    More analyst ratings

    $CPB
    $EMBC
    $IART
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Campbell's Reports First Quarter Fiscal 2026 Results; Reaffirms Full-Year Fiscal 2026 Guidance

    Net Sales decreased 3% to $2.7 billion and decreased 1% on an organic basis. Earnings Before Interest and Taxes (EBIT) decreased to $336 million. Adjusted EBIT decreased 11% to $383 million. Earnings Per Share (EPS) decreased to $0.65. Adjusted EPS decreased 13% to $0.77. Cash flow from operations was $224 million; returned $144 million to shareholders including $120 million in dividends. Entered into definitive agreements to acquire a 49% interest in La Regina, the producer of Rao's tomato-based pasta sauces. Acquisition solidifies Campbell's long-term strategic partnership with La Regina and is expected to fuel Rao's continued growth. Reaffirms full-year fiscal 2026 guidance.

    12/9/25 7:15:00 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference

    PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m ET A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS. About Integra LifeSciencesAt Integra LifeSciences, we are driven by our purpose of restoring patients' lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic

    12/1/25 4:30:00 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access

    PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, commends the Centers for Medicare & Medicaid Services (CMS) on its Calendar Year 2026 Medicare Physician Fee Schedule and Outpatient Prospective Payment System rules. All Integra dermal regenerative templates, decellularized dermal scaffolds and amniotic tissue membranes, which are classified as skin substitutes by CMS, are included in the ruling. These products – Integra® matrices, PriMatrix®, Cytal® and AmnioExcel® – utilize four different technology platforms for a wide range of complex cases in wound reconstruction. Integra's diverse p

    11/25/25 8:30:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on Campbell Soup with a new price target

    Analyst resumed coverage of Campbell Soup with a rating of Neutral and set a new price target of $33.00

    8/20/25 8:33:18 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Campbell Soup downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Campbell Soup from Overweight to Neutral and set a new price target of $34.00

    8/7/25 7:33:36 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Campbell Soup downgraded by Argus

    Argus downgraded Campbell Soup from Buy to Hold

    6/20/25 8:05:51 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Graves Jeffrey A bought $102,150 worth of shares (9,000 units at $11.35), increasing direct ownership by 28% to 41,086 units (SEC Form 4)

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    11/6/25 4:05:46 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Director Melcher David F bought $105,995 worth of shares (10,000 units at $10.60), increasing direct ownership by 13% to 86,681 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    5/23/25 4:35:56 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Director Melcher David F bought $177,646 worth of shares (13,000 units at $13.67), increasing direct ownership by 20% to 76,681 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    2/25/25 4:26:16 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by SVP, GC, Head Corp. Dev., Secy Mann Jeffrey Z

    4/A - Embecta Corp. (0001872789) (Issuer)

    12/3/25 4:48:42 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form 4 filed by SVP and CFO Elguicze Jacob

    4/A - Embecta Corp. (0001872789) (Issuer)

    12/3/25 4:45:38 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    EVP, Gen Counsel, and Corp Sec Brawley Charles A. Iii covered exercise/tax liability with 3,373 shares, decreasing direct ownership by 6% to 55,327 units (SEC Form 4)

    4 - CAMPBELL'S Co (0000016732) (Issuer)

    12/2/25 4:03:48 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    SEC Filings

    View All

    The Campbell's Company filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CAMPBELL'S Co (0000016732) (Filer)

    12/9/25 7:30:55 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    SEC Form 10-Q filed by The Campbell's Company

    10-Q - CAMPBELL'S Co (0000016732) (Filer)

    12/9/25 7:19:25 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    The Campbell's Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CAMPBELL'S Co (0000016732) (Filer)

    12/9/25 7:16:30 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    Leadership Updates

    Live Leadership Updates

    View All

    Campbell's Appoints Todd Cunfer Chief Financial Officer

    Established Finance Leader Brings Over Two Decades of Food Industry Experience The Campbell's Company (NASDAQ:CPB) (Campbell's) today announced the appointment of Todd Cunfer as Executive Vice President and Chief Financial Officer, effective Oct. 20, 2025. He will report to Campbell's President and Chief Executive Officer Mick Beekhuizen and become a member of the company's Operating Committee and an Executive Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251007967740/en/Todd Cunfer "I am excited to welcome Todd to the Campbell's team," said Beekhuizen. "With more than two decades of food industry experience, he brin

    10/7/25 4:30:00 PM ET
    $CPB
    $FRPT
    $HSY
    Packaged Foods
    Consumer Staples
    Specialty Foods

    Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer

    PRINCETON, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced the appointment of Dr. Raymond Turner as its new corporate vice president and chief medical officer. Dr. Turner brings more than 20 years of experience in clinical operations, having held senior leadership positions at some of the world's largest global MedTech companies. At Integra, Dr. Turner will lead worldwide medical affairs and clinical development activities including clinical research, clinical trial operations, evidence generation, medical safety and communications. In addition to his role with Integra, Dr. Turner will continue his clinical practice, providi

    9/22/25 8:30:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Campbell's Appoints Kelly L. Palumbo Senior Vice President, Controller and Chief Accounting Officer

    The Campbell's Company (NASDAQ:CPB) (Campbell's) today announced the appointment of Kelly L. Palumbo as Senior Vice President, Controller and Chief Accounting Officer, effective Sept. 22, 2025. She succeeds Stan Polomski who is being appointed to the newly created role of Senior Vice President, Business Process Optimization in the company's Enterprise Transformation Office. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904240330/en/Kelly Palumbo Palumbo will lead the corporate controller function and oversee corporate accounting, financial reporting, planning and controls. She will report to Carrie Anderson, Campbell's Execu

    9/4/25 4:30:00 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    Financials

    Live finance-specific insights

    View All

    Campbell's Reports First Quarter Fiscal 2026 Results; Reaffirms Full-Year Fiscal 2026 Guidance

    Net Sales decreased 3% to $2.7 billion and decreased 1% on an organic basis. Earnings Before Interest and Taxes (EBIT) decreased to $336 million. Adjusted EBIT decreased 11% to $383 million. Earnings Per Share (EPS) decreased to $0.65. Adjusted EPS decreased 13% to $0.77. Cash flow from operations was $224 million; returned $144 million to shareholders including $120 million in dividends. Entered into definitive agreements to acquire a 49% interest in La Regina, the producer of Rao's tomato-based pasta sauces. Acquisition solidifies Campbell's long-term strategic partnership with La Regina and is expected to fuel Rao's continued growth. Reaffirms full-year fiscal 2026 guidance.

    12/9/25 7:15:00 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance

    PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (NASDAQ:EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month periods ended September 30, 2025. "Our fourth quarter results were largely in line with our expectations, with revenue lower year over year due to several items we had previously anticipated, including the impact of advanced distributor ordering in the fourth quarter of fiscal year 2024 in advance of a potential U.S. port strike; the impact of advanced distributor ordering in the third quarter of fiscal year 2025 in advance of the U.S. July 4th holiday; and the continuing business dyna

    11/25/25 6:30:00 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    embecta Announces Quarterly Cash Dividend

    PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. ("embecta") (NASDAQ:EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company's common stock. The dividend is payable on December 18, 2025 to stockholders of record at the close of business on December 5, 2025. About embectaembecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social

    11/25/25 6:00:00 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Integra LifeSciences Holdings Corporation

    SC 13G - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/12/24 5:20:30 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Integra LifeSciences Holdings Corporation

    SC 13G/A - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/12/24 12:54:20 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Embecta Corp.

    SC 13G/A - Embecta Corp. (0001872789) (Subject)

    11/8/24 10:57:43 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care